Faecalibacterium prausnitzii strain HTF-F and its extracellular polymeric matrix attenuate clinical parameters in DSS-induced colitis

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Rossi, Oriana ^a   Khan, M Tanweer ^b   Schwarzer, Martin ^c   Hudcovic, Tomas ^c   Srutkova, Dagmar ^c   Duncan, Sylvia H ^d   Stolte, Ellen H ^a   Kozakova, Hana ^c   Flint, Harry J ^d   Samsom, Janneke N ^e   Harmsen, Hermie J M ^b   Wells, Jerry M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c INSTITUTE OF MATHEMATICS   (Czech Republic)

^d ROWETT RESEARCH INSTITUTE   (United Kingdom)

^e SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 17; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR FOXP3; AUTACOID; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; MEMBRANE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BIOFILM; BONE MARROW CELL; CELL AGGREGATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EX VIVO STUDY; EXTRACELLULAR MATRIX; EXTRACELLULAR POLYMERIC MATRIX; FAECALIBACTERIUM PRAUSNITZII; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATION; LACTOBACILLUS PLANTARUM; MONOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ULCERATIVE COLITIS; ANIMAL; CHEMICALLY INDUCED; COLITIS; DISEASE MODEL; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; INTESTINE MUCOSA; LYMPH NODE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHENOTYPE; RUMINOCOCCUS; SPLEEN; ULTRASTRUCTURE;

BACTERIA (MICROORGANISMS); FAECALIBACTERIUM PRAUSNITZII; FIRMICUTES;

ANIMALS; ANTIGENS, SURFACE; COLITIS; CYTOKINES; DENDRITIC CELLS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LYMPH NODES; MICE; PHENOTYPE; RUMINOCOCCUS; SPLEEN; TOLL-LIKE RECEPTOR 2; TRANSCRIPTION, GENETIC;

EID: 84929378129     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123013     Document Type: Article

References (27)

1. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut. 2003; 52(2):237-42. Epub 2003/01/14. PMID: 12524406
2. Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S. The gut microbiota in inflammatory bowel disease. Current pharmaceutical design. 2009; 15(13):1528-36. Epub 2009/05/16. PMID: 19442170
3. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007; 104(34):13780-5. Epub 2007/08/19. PMID: 17699621
4. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. The ISME journal. 2011; 5(2):220-30. Epub 2010/08/06. doi: 10.1038/ismej.2010.118 PMID: 20686513
5. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflammatory bowel diseases. 2009; 15(8):1183-9. Epub 2009/02/25. doi: 10.1002/ibd.20903 PMID: 19235886
6. Martin R, Chain F, Miquel S, Lu J, Gratadoux JJ, Sokol H, et al. The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflammatory bowel diseases. 2014; 20(3):417-30. Epub 2014/01/15. doi: 10.1097/01.MIB.0000440815.76627.64 PMID: 24418903
7. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008; 105(43):16731-6. Epub 2008/10/22. doi: 10.1073/pnas.0804812105 PMID: 18936492
8. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008; 453(7195):620-5. Epub 2008/05/30. doi: 10.1038/nature07008 PMID: 18509436
9. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010; 107(27):12204-9. Epub 2010/06/23. doi: 10.1073/pnas.0909122107 PMID: 20566854
10. Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, Goulding D, et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A. 2011; 109(6):2108-13.
11. Barcenilla A, Pryde SE, Martin J, Duncan SH, Stewart CS, Henderson C, et al. Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut. Applied and environmental microbiology. 2000.
12. Duncan SH. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. International Journal of Systematic and Evolutionary Microbiology. 2002; 52(6):2141-6. PMID: 12508881
13. Lopez-Siles M, Khan TM, Duncan SH, Harmsen HJ, Garcia-Gil LJ, Flint HJ. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Applied and environmental microbiology. 2012; 78(2):420-8. Epub 2011/11/22. doi: 10.1128/AEM.06858-11 PMID: 22101049
14. Schabussova I, Hufnagl K, Tang ML, Hoflehner E, Wagner A, Loupal G, et al. Perinatal maternal administration of Lactobacillus paracasei NCC 2461 prevents allergic inflammation in a mouse model of birch pollen allergy. PLoS One. 2012; 7(7):e40271. Epub 2012/07/14. doi: 10.1371/journal.pone.0040271 PMID: 22792257
15. Ricciardi A, Parente E., Aquino M., Clementi F. Use of desalting gel for the rapid separation of simple sugars from exopolysaccharides produced by lactic acid bacteria. Biotechnol Tech. 1998; 12:649-52.
16. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000; 132:365-86. Epub 1999/11/05. PMID: 10547847
17. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic acids research. 2001; 29(9):e45. Epub 2001/05/09. PMID: 11328886
18. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. Journal of immunological methods. 1999; 223(1):77-92. Epub 1999/02/26. PMID: 10037236
19. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Laboratory investigation; a journal of technical methods and pathology. 1993; 69(2):238-49. Epub 1993/08/01. PMID: 8350599
20. Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010; 8(9):623-33. Epub 2010/08/03. doi: 10.1038/nrmicro2415 PMID: 20676145
21. Meijerink M, Ferrando ML, Lammers G, Taverne N, Smith HE, Wells JM. Immunomodulatory effects of Streptococcus suis capsule type on human dendritic cell responses, phagocytosis and intracellular survival. PLoS One. 2012; 7(4):e35849. Epub 2012/05/05. doi: 10.1371/journal.pone.0035849 PMID: 22558240
22. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Alimentary pharmacology & therapeutics. 2008; 27(2):104-19. Epub 2007/11/02.
23. Hamer HM, Jonkers DM, Vanhoutvin SA, Troost FJ, Rijkers G, de Bruine A, et al. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clin Nutr. 2010; 29(6):738-44. Epub 2010/05/18. doi: 10.1016/j.clnu.2010.04.002 PMID: 20471725
24. Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity. 2011; 34(5):794-806. Epub 2011/05/21. doi: 10.1016/j.immuni.2011.03.021 PMID: 21596591
25. Veenbergen S, Samsom JN. Maintenance of small intestinal and colonic tolerance by IL-10-producing regulatory T cell subsets. Curr Opin Immunol. 2012; 24(3):269-76. Epub 2012/04/17. doi: 10.1016/j.coi.2012.03.004 PMID: 22503960
26. Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H, et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol. 2009; 10(11):1178-84. Epub 2009/09/29. doi: 10.1038/ni.1791 PMID: 19783988
27. Manuzak J, Dillon S, Wilson C. Differential Interleukin-10 (IL-10) and IL-23 Production by Human Blood Monocytes and Dendritic Cells in Response to Commensal Enteric Bacteria. Clinical and vaccine immunology: CVI. 2012; 19(8):1207-17. Epub 2012/06/15. doi: 10.1128/CVI.00282-12 PMID: 22695160